Search
for
Sort by
Research 961–990 of 1000+
- Hair Follicle Disruption Facilitates Pathogenesis to UVB-Induced Cutaneous Inflammation and Basal Cell Carcinoma Development in Ptch+/− Mice
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Hair Loss Induced by Lopinavir-Ritonavir
- Differential effects of Wnt5a on the proliferation, differentiation and inflammatory response of keratinocytes
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- CD201+ fascia progenitors choreograph injury repair
- Metabolic Syndrome and Skin Disease: Potential Connection and Risk
- Low-level light therapy (LLLT) for cosmetics and dermatology
- The eosinophilia-myalgia syndrome
- Dissecting hair breakage in alopecia areata: the central role of dysregulated cysteine homeostasis
- Oxidative stress and alopecia areata
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Evaluation of Animal Models Suitable for Hair Research and Regeneration
- Cutaneous Reactions to Drugs
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Cytokines
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Current and future pharmacotherapy for alopecia areata
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Exploring phytoandrogens: A review of their potential in health and medicine
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- Telogen Effluvium
- Alopecia Areata
- Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma
- Bald scalps and wrinkles
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- A Comprehensive Review of Management of Patients with Infertility having Polycystic Ovarian Syndrome
- Pharmacotherapy of alopecia areata